लोड हो रहा है...

Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report

A 67-year-old male patient who was diagnosed with primary myelofibrosis 4 years ago did not respond to conventional therapies. The splenomegaly progressively increased, which caused spleen infarctions and led to the decision to perform a splenectomy procedure. After splenectomy, the patient started...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Turk J Haematol
मुख्य लेखकों: Aylı, Meltem, Özcan, Muhit, Cengiz Seval, Güldane
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Galenos Publishing 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451489/
https://ncbi.nlm.nih.gov/pubmed/26316489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.2013.0338
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!